Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Codexis (CDXS) Research & Development (2016 - 2025)

Codexis (CDXS) has 16 years of Research & Development data on record, last reported at $11.7 million in Q4 2025.

  • For Q4 2025, Research & Development fell 3.12% year-over-year to $11.7 million; the TTM value through Dec 2025 reached $52.3 million, up 13.06%, while the annual FY2025 figure was $52.3 million, 13.06% up from the prior year.
  • Research & Development reached $11.7 million in Q4 2025 per CDXS's latest filing, down from $13.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $21.8 million in Q3 2022 and bottomed at $11.2 million in Q4 2023.
  • Average Research & Development over 5 years is $14.7 million, with a median of $13.7 million recorded in 2023.
  • Peak YoY movement for Research & Development: soared 68.52% in 2022, then tumbled 42.94% in 2023.
  • A 5-year view of Research & Development shows it stood at $16.4 million in 2021, then rose by 20.37% to $19.7 million in 2022, then tumbled by 42.94% to $11.2 million in 2023, then rose by 7.7% to $12.1 million in 2024, then fell by 3.12% to $11.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $11.7 million in Q4 2025, $13.9 million in Q3 2025, and $13.8 million in Q2 2025.